Allianz Asset Management GmbH Sells 16,045 Shares of DaVita Inc. (NYSE:DVA)

Allianz Asset Management GmbH decreased its stake in shares of DaVita Inc. (NYSE:DVA) by 2.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 534,143 shares of the company’s stock after selling 16,045 shares during the quarter. Allianz Asset Management GmbH’s holdings in DaVita were worth $79,881,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Hussman Strategic Advisors Inc. raised its position in shares of DaVita by 200.0% in the 4th quarter. Hussman Strategic Advisors Inc. now owns 25,200 shares of the company’s stock worth $3,769,000 after purchasing an additional 16,800 shares during the last quarter. Convergence Investment Partners LLC increased its stake in DaVita by 33.2% during the 4th quarter. Convergence Investment Partners LLC now owns 11,389 shares of the company’s stock valued at $1,703,000 after purchasing an additional 2,836 shares in the last quarter. Kentucky Retirement Systems Insurance Trust Fund raised its holdings in DaVita by 357.7% in the fourth quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 6,252 shares of the company’s stock worth $935,000 after buying an additional 4,886 shares during the last quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in shares of DaVita in the fourth quarter worth approximately $597,000. Finally, Venturi Wealth Management LLC grew its holdings in shares of DaVita by 59.8% during the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock valued at $61,000 after buying an additional 152 shares during the last quarter. 90.12% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, Barclays boosted their price objective on shares of DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a report on Tuesday. One analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company. According to MarketBeat, DaVita presently has an average rating of “Hold” and a consensus target price of $162.80.

DaVita Stock Performance

Shares of DVA stock opened at $142.33 on Friday. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. The company has a 50 day moving average price of $161.03 and a 200-day moving average price of $157.86. DaVita Inc. has a 52 week low of $120.78 and a 52 week high of $179.60. The firm has a market capitalization of $11.39 billion, a PE ratio of 13.25, a P/E/G ratio of 1.07 and a beta of 0.94.

DaVita (NYSE:DVA) last posted its earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. As a group, equities research analysts expect that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.